CHG-2022-0103

Formulation Change for Tiotropizone. Facility Change for Tiotropizone — major revision. Impacts 5 markets and 2 variations.

Change Number
CHG-2022-0103
Type
Formulation Change
Product
Tiotropizone
Status
Completed
Owner
Priya Sharma
Initiated
2023-06-14
Description

Facility Change for Tiotropizone — major revision

Impacted Markets (5)
JP — JapanES — SpainSA — Saudi ArabiaPL — PolandAT — Austria
Impacted Modules
3.2.S4.2.13.2.P5.3.5
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved